| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |